1. Home
  2. ORGO vs HIO Comparison

ORGO vs HIO Comparison

Compare ORGO & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$2.52

Market Cap

299.8M

Sector

Health Care

ML Signal

N/A

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

N/A

Current Price

$3.59

Market Cap

349.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ORGO
HIO
Founded
1985
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
299.8M
349.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ORGO
HIO
Price
$2.52
$3.59
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
937.0K
346.4K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
10.33%
EPS Growth
1600.00
N/A
EPS
N/A
N/A
Revenue
$564,169,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$26.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.04
N/A
52 Week Low
$2.04
$3.52
52 Week High
$7.08
$4.05

Technical Indicators

Market Signals
Indicator
ORGO
HIO
Relative Strength Index (RSI) 51.37 41.82
Support Level $2.20 $3.53
Resistance Level $2.67 $3.70
Average True Range (ATR) 0.14 0.03
MACD -0.01 -0.00
Stochastic Oscillator 62.12 20.83

Price Performance

Historical Comparison
ORGO
HIO

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: